Patient Guide: A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 21 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06122649
Status: ACTIVE_NOT_RECRUITING
Condition: Plaque Psoriasis
Phase: PHASE3

Find a Study Location Near You

This study is available at 21 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Beijing, Beijing Municipality
  • Beijing, Beijing Municipality
  • Fuzhou, Fujian
  • • And 18 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily